Jade Biosciences (JBIO) Interest Expenses (2021 - 2024)

Jade Biosciences (JBIO) has 7 years of Interest Expenses data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Interest Expenses fell 62.14% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 62.79% YoY) and the FY2025 annual result came in at $3.6 million, down 52.36% from the prior year.
• Interest Expenses retreated to $1.1 million in Q1 2026, from $29.3 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $93.5 million in Q1 2024 to a low of -$70000.0 in Q4 2022.
• A 5-year average of $24.5 million and a median of $29.3 million in 2025 frame the typical range for Interest Expenses.
• The widest YoY moves for Interest Expenses: up 4111000.0% in 2022, down 6900.0% in 2022.
• Tracing JBIO's Interest Expenses over 5 years: stood at -$70000.0 in 2022, then surged by 270.0% to $119000.0 in 2023, then sank by 89.92% to $12000.0 in 2024, then soared by 244108.33% to $29.3 million in 2025, then slumped by 96.38% to $1.1 million in 2026.
• The last three Interest Expenses figures came in at $1.1 million (Q1 2026), $29.3 million (Q3 2025), and $42.2 million (Q2 2025), per Business Quant data.